Jean-pierre Bizzari - Net Worth and Insider Trading
Jean-pierre Bizzari Net Worth
The estimated net worth of Jean-pierre Bizzari is at least $3 Million dollars as of 2024-09-20. Jean-pierre Bizzari is the Director of Halozyme Therapeutics Inc and owns about 52,544 shares of Halozyme Therapeutics Inc (HALO) stock worth over $3 Million. Jean-pierre Bizzari is also the Director of ADC Therapeutics SA and owns about 79,502 shares of ADC Therapeutics SA (ADCT) stock worth over $255,201. Details can be seen in Jean-pierre Bizzari's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jean-pierre Bizzari has not made any transactions after 2024-06-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jean-pierre Bizzari
Jean-pierre Bizzari Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jean-pierre Bizzari owns 4 companies in total, including Halozyme Therapeutics Inc (HALO) , Pieris Pharmaceuticals Inc (PIRS) , and Celator Pharmaceuticals Inc (CPXX) among others .
Click here to see the complete history of Jean-pierre Bizzari’s form 4 insider trades.
Insider Ownership Summary of Jean-pierre Bizzari
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2021-08-25 | director |
| PIRS | Pieris Pharmaceuticals Inc | 2016-02-16 | director |
| CPXX | Celator Pharmaceuticals Inc | 2016-07-12 | director |
 | | 2023-08-23 | director |
Jean-pierre Bizzari Latest Holdings Summary
Jean-pierre Bizzari currently owns a total of 2 stocks. Among these stocks, Jean-pierre Bizzari owns 52,544 shares of Halozyme Therapeutics Inc (HALO) as of August 25, 2021, with a value of $3 Million and a weighting of 92.45%. Jean-pierre Bizzari also owns 79,502 shares of ADC Therapeutics SA (ADCT) as of June 17, 2024, with a value of $255,201 and a weighting of 7.55%.
Latest Holdings of Jean-pierre Bizzari
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2021-08-25 | 52,544 | 59.51 | 3,126,893 |
| ADCT | ADC Therapeutics SA | 2024-06-17 | 79,502 | 3.21 | 255,201 |
Holding Weightings of Jean-pierre Bizzari
Jean-pierre Bizzari Form 4 Trading Tracker
According to the SEC Form 4 filings, Jean-pierre Bizzari has made a total of 1 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Halozyme Therapeutics Inc is the sale of 35,000 shares on August 25, 2021, which brought Jean-pierre Bizzari around $1 Million.
According to the SEC Form 4 filings, Jean-pierre Bizzari has made a total of 1 transactions in ADC Therapeutics SA (ADCT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in ADC Therapeutics SA is the sale of 6,995 shares on June 17, 2024, which brought Jean-pierre Bizzari around $20,216.
Insider Trading History of Jean-pierre Bizzari
- 1
Jean-pierre Bizzari Trading Performance
Jean-pierre Bizzari Ownership Network
Jean-pierre Bizzari Owned Company Details
What does Halozyme Therapeutics Inc do?
Who are the key executives at Halozyme Therapeutics Inc?
Jean-pierre Bizzari is the director of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Technical Officer Michael J. Labarre , director & President and CEO Helen Torley , and SVP & Chief Financial Officer Nicole Labrosse .
Halozyme Therapeutics Inc (HALO) Insider Trades Summary
Over the past 18 months, Jean-pierre Bizzari made no insider transaction in Halozyme Therapeutics Inc (HALO). Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 270,000 shares made by Michael J. Labarre , a net sale of 150,000 shares made by Helen Torley , and a net sale of 49,881 shares made by Matthew L. Posard .
In summary, during the past 3 months, insiders sold 184,881 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 184,881 shares. During the past 18 months, 524,881 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 524,881 shares.
Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Halozyme Therapeutics Inc Insider Transactions
Jean-pierre Bizzari Mailing Address
Above is the net worth, insider trading, and ownership report for Jean-pierre Bizzari. You might contact Jean-pierre Bizzari via mailing address: 235 Laurel Ln, Haverfold Pa 19041.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
